(Q30778784)

26 June 2017

1 reference

title

Tissue-specific MR contrast agents (English)

1 reference

26 June 2017

1 reference

Hanns-Joachim Weinmann

1

1 reference

26 June 2017

Wolfgang Ebert

2

1 reference

26 June 2017

Bernd Misselwitz

3

1 reference

26 June 2017

Heribert Schmitt-Willich

4

1 reference

26 June 2017

1 April 2003

1 reference

European Journal of Radiology

26 June 2017

1 reference

26 June 2017

46

1 reference

26 June 2017

1

1 reference

26 June 2017

33-44

1 reference

Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function

26 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Imaging of myocardial infarction: comparison of magnevist and gadophrin-3 in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Mechanism of gadophrin-2 accumulation in tumor necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Paramagnetic metalloporphyrins: infarct avid contrast agents for diagnosis of acute myocardial infarction by MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

MR imaging of the breast with Gd-DTPA: use and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Dynamic imaging with lanthanide chelates in normal brain: Contrast due to magnetic susceptibility effects

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Iron-EHPG as an hepatobiliary MR contrast agent: initial imaging and biodistribution studies

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Technique for MR imaging of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: results of a Phase III cli

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

MR receptor imaging: ultrasmall iron oxide particles targeted to asialoglycoprotein receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

MION-ASF: biokinetics of an MR receptor agent

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Hepatobiliary MR imaging: first human experience with MnDPDP

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Metabolism of mangafodipir trisodium (MnDPDP), a new contrast medium for magnetic resonance imaging, in beagle dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Effects of manganese dipyridoxyl diphosphate, dipyridoxyl diphosphate--, and manganese chloride on cardiac function. An experimental study in the Langendorff perfused rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Mn-DPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Detection and characterization of primary liver cancer in rats by MS-264-enhanced MRI

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Mechanism of hepatic uptake of gadoxetate disodium.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Pharmacokinetics and tissue distribution in animals of gadobenate ion, the magnetic resonance imaging contrast enhancing component of gadobenate dimeglumine 0.5 M solution for injection (MultiHance)

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Evaluation of the Accuracy of Gadobenate Dimeglumine-Enhanced MR Imaging in the Detection and Characterization of Focal Liver Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Pharmacokinetics of the liver-specific contrast agent Gd-EOB-DTPA in relation to contrast-enhanced liver imaging in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Detection of focal liver lesions: CT of the hepatobiliary system with gadoxetic acid disodium, or Gd-EOB-DTPA.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Contrast-enhanced MRI of focal liver tumors using a hepatobiliary MR contrast agent: detection and differential diagnosis using Gd-EOB-DTPA-enhanced versus Gd-DTPA-enhanced MRI in the same patient

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Evaluation of gadolinium 2,5-BPA-DO3A, a new macrocyclic hepatobiliary chelate, in normal liver and metastatic disease on high field magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

CT evaluation of hepatic and splenic trauma with EOE-13. An experimental study in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

A new liposomal liver-specific contrast agent for CT: first human phase-I clinical trial assessing efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Safety and pharmacokinetics of a new liposomal liver-specific contrast agent for CT: results of clinical testing in nonpatient volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Spio-MR Imaging versus Double-Phase Spiral CT in Detecting Malignant Lesions of the Liver

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Biodistribution and clearance of liposomal gadolinium-DTPA.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

The design of liposomal paramagnetic MR agents: effect of vesicle size upon the relaxivity of surface-incorporated lipophilic chelates

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Gadolinium complexes of [(myristoyloxy)propyl]diethylenetriaminetetraacetate: new lipophilic, fatty acyl conjugated NMR contrast agents

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Liposomes as MR contrast agents: Pros and cons

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

MS-325: a small-molecule vascular imaging agent for magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Steady-state and dynamic MR angiography with MS-325: initial experience in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Contrast agent-enhanced magnetic resonance imaging of skeletal muscle damage in animal models of muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Preclinical profile and clinical potential of gadocoletic acid trisodium salt (B22956/1), a new intravascular contrast medium for MRI

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

B22956/1, a new intravascular contrast agent for MRI: first administration to humans--preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Physical, chemical, and biological evaluations of P760: a new gadolinium complex characterized by a low rate of interstitial diffusion

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Safety and pharmacokinetics of p792, a new blood-pool agent: results of clinical testing in nonpatient volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Comparison of the contrast-enhancing properties of albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: and experimental study in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Biodistribution and Magnetic Resonance Imaging of Cross-Linked DTPA Polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

In Vivo and In Vitro Evaluation of Gd-DTPA-Polylysine as a Macromolecular Contrast Agent for Magnetic Resonance Imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Polymetallic macromolecules are potential contrast agents of improved efficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Assessing tumor angiogenesis using macromolecular MR imaging contrast media.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Starburst-Dendrimere: Kontrolle von Größe, Gestalt, Oberflächenchemie, Topologie und Flexibilität beim Übergang von Atomen zu makroskopischer Materie

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Magnetic Resonance Angiography With Gadomer-17

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Single-vessel coronary artery stenosis: myocardial perfusion imaging with Gadomer-17 first-pass MR imaging in a swine model of comparison with gadopentetate dimeglumine

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Direct comparison of an intravascular and an extracellular contrast agent for quantification of myocardial perfusion. Cardiac MRI Group

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Quantification of tumor microvascular permeability in human glioma xenografts using dynamic T1 MRI with Gadomer-17

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Investigation of longitudinal vascular changes in control and chemotherapy-treated tumors to serve as therapeutic efficacy predictors

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Dynamic contrast-enhanced MR imaging of bacterial abscess and VX2 carcinoma in rabbits: comparison of gadopentetate dimeglumine and a macromolecular contrast agent

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Simultaneous MRI measurement of blood flow, blood volume, and capillary permeability in mammary tumors using two different contrast agents

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Enhancement of MR angiography with iron oxide: preliminary studies in whole-blood phantom and in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Phase I clinical evaluation of a new iron oxide MR contrast agent.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Pulmonary MR angiography with ultrasmall superparamagnetic iron oxide particles as a blood pool agent and a navigator echo for respiratory gating: pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

First-pass and equilibrium phase MRA following intravenous bolus injection of SH U 555 C: Phase I clinical trial in elderly volunteers with risk factors for arterial vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Coronary MR angiography: experimental results with a monomer-stabilized blood pool contrast medium

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Interstitial MR lymphography with gadoterate meglumine: initial experience in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Interstitial T1-weighted MR lymphography: lipophilic perfluorinated gadolinium chelates in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Interstitial magnetic resonance lymphography using a polymeric t1 contrast agent: initial experience with Gadomer-17

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

MR lymphography with iron oxide particles: dose-response studies and pulse sequence optimization in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

MR Lymphography Using Iron Oxide Particles

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Preliminary clinical experience with AMI 227

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) -- results of a phase-III multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Progression and regression of atherosclerotic lesions: monitoring with serial noninvasive magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Phototherapy of cancer and atheromatous plaque with texaphyrins

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Uptake of hematoporphyrin derivative by atheromatous plaques: studies in human in vitro and rabbit in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Photofrin II uptake by atheroma in atherosclerotic rabbits. Fluorescence and high performance liquid chromatographic analysis on post-mortem aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

MRI with mangafodipir trisodium in the detection of pancreatic tumours: comparison with helical CT

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Functioning acinar cell pancreatic carcinoma: diagnosis on mangafodipir trisodium (Mn-DPDP)-enhanced MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Autoradiography of manganese: accumulation and retention in the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Monoclonal antibodies labeled with polymeric paramagnetic ion chelates

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Magnetic resonance imaging of gadolinium-labeled monoclonal antibody polymers directed at human T lymphocytes implanted in canine brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Magnetic resonance imaging studies on nude mice grafted with colorectal adenocarcinoma using gadolinium-labeled monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Magnetic resonance imaging of esophageal squamous cell carcinoma using magnetite particles coated with anti-epidermal growth factor receptor antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

In vivo studies of Gd-DTPA-monoclonal antibody and gd-porphyrins: potential magnetic resonance imaging contrast agents for melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

New perspectives in cell adhesion: RGD and integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

RGD and other recognition sequences for integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Thrombus imaging using technetium-99m-labeled high-potency GPIIb/IIIa receptor antagonists. Chemistry and initial biological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Enhanced detection of thrombi with a novel fibrin-targeted magnetic resonance imaging agent

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

The use of a thrombus-specific ultrasound contrast agent to detect thrombus in arteriovenous fistulae

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

A targeted contrast agent for magnetic resonance imaging of thrombus: implications of spatial resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Paramagnetic metalloporphyrins: from enhancers of malignant tumors to markers of myocardial infarcts

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Irreversibly damaged myocardium at MR imaging with a necrotic tissue-specific contrast agent in a cat model

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Occlusive myocardial infarction: investigation of bis-gadolinium mesoporphyrins-enhanced T1-weighted MR imaging in a cat model

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2802%2900332-7

7 January 2021

10.1016/S0720-048X(02)00332-7

Identifiers

DOI

1 reference

release_eoldaatqtjbvpfrld34ithswru

26 June 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/eoldaatqtjbvpfrld34ithswru

24 November 2022

mapped directly with Wikidata item

1 reference